2023 Q2 Form 10-K Financial Statement

#000121390023030000 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $44.56K $53.06K $207.9K
YoY Change -7.71% 29.29% -21.32%
Cost Of Revenue $13.74K -$28.80K $60.87K
YoY Change 522.0% -351.97% -37.68%
Gross Profit $19.68K $81.86K $95.02K
YoY Change -42.12% 176.46% -42.94%
Gross Profit Margin 44.17% 154.28% 45.72%
Selling, General & Admin -$25.85K $91.72K
YoY Change -194.41% -12.28%
% of Gross Profit -31.58% 96.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit 0.0% 0.0%
Operating Expenses $78.28K -$25.85K $91.72K
YoY Change 9.61% -194.41% -12.28%
Operating Profit -$58.60K $107.7K $3.300K
YoY Change 56.63% 4730.04% -94.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $107.7K $3.300K
YoY Change 4751.8% -94.65%
Income Tax
% Of Pretax Income
Net Earnings -$58.60K $107.7K $3.300K
YoY Change 56.63% 4751.8% -94.65%
Net Earnings / Revenue -131.5% 203.0% 1.59%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 100.0M shares 100.0M shares 100.0M shares
Diluted Shares Outstanding 100.0M shares 100.0M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.58K $30.58K
YoY Change -72.98% -72.98%
Cash & Equivalents $15.14K $30.58K
Short-Term Investments
Other Short-Term Assets $9.250K $9.250K
YoY Change
Inventory $64.47K $85.29K $85.29K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $81.36K $125.1K $125.1K
YoY Change -47.9% -28.64% -28.64%
LONG-TERM ASSETS
Property, Plant & Equipment $57.00K $57.00K
YoY Change -50.43% -50.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $57.00K $57.00K $57.00K
YoY Change -48.65% -50.43% -50.43%
TOTAL ASSETS
Total Short-Term Assets $81.36K $125.1K $125.1K
Total Long-Term Assets $57.00K $57.00K $57.00K
Total Assets $138.4K $182.1K $182.1K
YoY Change -48.21% -37.27% -37.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.90K $1.400K $1.400K
YoY Change -72.98% -97.62% -97.62%
Accrued Expenses $132.3K $132.3K
YoY Change 83.44% 83.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $172.9K $133.7K $133.7K
YoY Change -14.2% 1.55% 1.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $42.25K $42.25K
YoY Change -56.1% -56.1%
Total Long-Term Liabilities $42.25K $42.25K
YoY Change -56.1% -56.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $172.9K $133.7K $133.7K
Total Long-Term Liabilities $42.25K $42.25K
Total Liabilities $202.9K $175.9K $176.0K
YoY Change -31.86% -22.8% -22.8%
SHAREHOLDERS EQUITY
Retained Earnings -$794.1K -$723.4K
YoY Change 4.46% 8.43%
Common Stock $100.0K $100.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$64.55K $6.170K $6.170K
YoY Change
Total Liabilities & Shareholders Equity $138.4K $182.1K $182.1K
YoY Change -48.21% -37.27% -37.27%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$58.60K $107.7K $3.300K
YoY Change 56.63% 4751.8% -94.65%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$37.75K -$84.61K
YoY Change -574.84% -206.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $24.00K $58.00K
YoY Change 415.56%
Cash From Investing Activities $24.00K $58.00K
YoY Change 415.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.51K -$55.98K
YoY Change 227.05% 4488.52%
NET CHANGE
Cash From Operating Activities -37.75K -$84.61K
Cash From Investing Activities 24.00K $58.00K
Cash From Financing Activities -25.51K -$55.98K
Net Change In Cash -39.26K -$82.59K
YoY Change -26273.33% -192.66%
FREE CASH FLOW
Cash From Operating Activities -$37.75K -$84.61K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021 higr Forgiveness Of Note Receivable Related Party
ForgivenessOfNoteReceivableRelatedParty
usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1400 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
62160 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
9250 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
125117 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
175329 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115000 usd
CY2022Q4 us-gaap Assets
Assets
182117 usd
CY2021Q4 us-gaap Assets
Assets
290329 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity File Number
EntityFileNumber
000-56200
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2218131
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
621 South Virgil Ave,
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
#460
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles,
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90005
CY2022 dei City Area Code
CityAreaCode
(213)
CY2022 dei Local Phone Number
LocalPhoneNumber
219-7746
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100000000 shares
CY2022 dei Auditor Firm
AuditorFirmId
6662
CY2022 dei Auditor Name
AuditorName
M. N. VijayKumar
CY2022 dei Auditor Location
AuditorLocation
Bangalore, India
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30577 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113169 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
85290 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
58740 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
117547 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
110940 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14750 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18750 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
800 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
133697 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
189230 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42250 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96250 usd
CY2022Q4 us-gaap Liabilities
Liabilities
175947 usd
CY2021Q4 us-gaap Liabilities
Liabilities
285480 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
629566 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
629566 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-723396 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-724716 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6170 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4850 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182117 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
290329 usd
CY2022 us-gaap Revenues
Revenues
207854 usd
CY2021 us-gaap Revenues
Revenues
264194 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
51964 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
66049 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
60870 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
89190 usd
CY2022 us-gaap Gross Profit
GrossProfit
95021 usd
CY2021 us-gaap Gross Profit
GrossProfit
108955 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
40700 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
58000 usd
CY2022 us-gaap Equipment Expense
EquipmentExpense
30000 usd
CY2021 us-gaap Equipment Expense
EquipmentExpense
30000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21021 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18069 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
91721 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
106069 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
3300 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2886 usd
CY2021 us-gaap Interest Expense
InterestExpense
307 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-307 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3300 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2579 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100000000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100000000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-236 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-12782 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-13018 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
10000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5289 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2579 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4850 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1980 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3300 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6170 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3300 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2579 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23130 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14400 usd
CY2022 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
9250 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-57340 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
36540 usd
CY2022 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
6608 usd
CY2021 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
66049 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-714 usd
CY2021 us-gaap Increase Decrease In Notes Payable Related Parties Current
IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
-2465 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-800 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4000 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84612 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77589 usd
CY2022 higr Right Of Use Asset Related Party Current
RightOfUseAssetRelatedPartyCurrent
58000 usd
CY2021 higr Right Of Use Asset Related Party Current
RightOfUseAssetRelatedPartyCurrent
11250 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
58000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11250 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000 usd
CY2021 higr Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
-15000 usd
CY2022 higr Proceeds From Operating Lease Obligation
ProceedsFromOperatingLeaseObligation
-54000 usd
CY2022 higr Retained Earnings
RetainedEarnings
-1980 usd
CY2021 higr Retained Earnings
RetainedEarnings
5289 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55980 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82592 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89128 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113169 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24041 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30577 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113169 usd
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
70000000 shares
CY2019Q4 higr Stock During Period Exchange Rate On Cash
StockDuringPeriodExchangeRateOnCash
225000 usd
CY2020Q1 higr Licensing Agreement Percentage
LicensingAgreementPercentage
0.25 pure
CY2020Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1000 usd
CY2020Q1 higr Less Than Gross Revenues
LessThanGrossRevenues
1000 usd
CY2020Q1 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
30000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Use of estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
CY2020Q1 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The lease begins March 16, 2020 and matures March 16, 2025.
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
0 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Reclassifications</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the financial statements for the year ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
CY2022 higr Royalty Payment Percentage
RoyaltyPaymentPercentage
0.25 pure
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50 pure
CY2020Q1 higr Description Of Licensing Agreement
DescriptionOfLicensingAgreement
On March 19, 2020, the Company entered in a licensing agreement with SellaCare, Inc. for the licensing of Patents and all future products developed by the SellaCare, Inc. The licensing agreement calls for the Company to pay 25% of all Gross revenues or $1,000, whichever is greater and not less than $1,000, beginning April 30, 2020 and payable the 15th of every month thereafter.
CY2020 higr License Expense
LicenseExpense
44891 usd
CY2020Q1 us-gaap Payments For Rent
PaymentsForRent
30000 usd
CY2020Q1 us-gaap Payments For Rent
PaymentsForRent
30000 usd
CY2020Q1 higr Debt Instruments Maturity Date Description
DebtInstrumentsMaturityDateDescription
The lease begins March 16, 2020 and matures March 16, 2025.
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
0 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
20750 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
30000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
6250 usd
CY2022Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
57000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
93000 usd
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
150000 usd
CY2022Q4 higr Less Current Portion
LessCurrentPortion
0 usd
CY2022Q4 higr Lease Obligation Long Term
LeaseObligationLongTerm
57000 usd
CY2022Q4 higr Finance Leases Right Of Use Asset
FinanceLeasesRightOfUseAsset
57000 usd
CY2021Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100000000 shares
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2022 us-gaap Increase Decrease In Notes Payable Related Parties Current
IncreaseDecreaseInNotesPayableRelatedPartiesCurrent
usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2022 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
usd
CY2021 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 higr Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
usd
CY2021 higr Proceeds From Operating Lease Obligation
ProceedsFromOperatingLeaseObligation
usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022 higr Forgiveness Of Note Receivable Related Party
ForgivenessOfNoteReceivableRelatedParty
usd
CY2022 higr Issued Stock
IssuedStock
usd
CY2021 higr Issued Stock
IssuedStock
usd
CY2022 higr Right Of Use Asset Operating Lease
RightOfUseAssetOperatingLease
usd
CY2021 higr Right Of Use Asset Operating Lease
RightOfUseAssetOperatingLease
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001807616
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd

Files In Submission

Name View Source Status
0001213900-23-030000-index-headers.html Edgar Link pending
0001213900-23-030000-index.html Edgar Link pending
0001213900-23-030000.txt Edgar Link pending
0001213900-23-030000-xbrl.zip Edgar Link pending
f10k2022ex31-1_higreatgroup.htm Edgar Link pending
f10k2022ex32-1_higreatgroup.htm Edgar Link pending
f10k2022ex4-5_higreatgroup.htm Edgar Link pending
f10k2022_higreatgroup.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10k2022_higreatgroup_htm.xml Edgar Link completed
higr-20221231.xsd Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
higr-20221231_def.xml Edgar Link unprocessable
higr-20221231_pre.xml Edgar Link unprocessable
higr-20221231_lab.xml Edgar Link unprocessable
higr-20221231_cal.xml Edgar Link unprocessable